Prelude Capital Management, LLC Bio Rad Laboratories, Inc. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
A detailed history of Prelude Capital Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 22,025 shares of BIO stock, worth $7.31 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
22,025
Previous 53,523
58.85%
Holding current value
$7.31 Million
Previous $18.5 Million
67.51%
% of portfolio
0.43%
Previous 1.0%
Shares
22 transactions
Others Institutions Holding BIO
# of Institutions
461Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$788 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$514 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$374 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$285 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$219 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.17B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...